Endothelial Keratoplasty (EK) has rapidly replaced penetrating keratoplasty (PKP) as the procedure of choice for treatment of endothelial diseases accounting for over 50% of all transplants performed in the United States in 20126. PKP is limited by prolonged visual rehabilitation with high astigmatism and refractive instability, loss of globe integrity and suture-related complications. Early generation EK procedures, including Deep Lamellar Endothelial Keratoplasty (DLEK) involved manual dissection of corneal stroma with transplantation of partial thickness donor tissue. These procedures were successful in transplanting donor endothelial tissue while maintaining an intact corneal surface but were technically challenging and resulted in limited best corrected visual acuity due to an irregular corneal lamellar interface1. The current EK procedure of choice is Descemet’s Stripping Endothelial Keratoplasty (DSEK) which offers corneal clarity with faster recovery of vision, minimizes postoperative refractive error and astigmatism, and decreases risk of traumatic wound dehiscence while maintaining the corneal surface7. This procedure involves removal of the diseased Descemet's membrane and endothelium and replacement with partial thickness donor corneal tissue comprising a new endothelial cell layer. The donor cornea is dissected with a microkeratome to prepare the posterior tissue being transplanted8. Preparation of the donor tissue by the eye-banks has been instrumental in the rapid growth and, arguably, the success of this procedure. The near 16-fold increase in DSEK procedures in the United States between 2005 and 2012 corresponds with almost half of the tissue currently being prepared by the eye-banks6.
Although DSEK can improve visual acuity to 20/40 or better, most patients do not achieve 20/20 vision due to stromal interface haze and increased light scatter from the addition of donor stromal tissue7. The EK surgical technique has progressed to Descemet’s Membrane Endothelial Keratoplasty (DMEK) which involves transplantation of only donor Descemet's membrane (DM) and endothelium. This procedure has a higher proportion of patients who achieve 20/20 vision, faster visual recovery, and a lower risk of endothelial rejection9. However, preparation of donor tissue is more challenging due to the thinner graft dimensions.